How can we measure insulin sensitivity/resistance?

Diabetes and Metabolism

Volumn 37, Issue 3, 2011, Pages 179-188

  Antuna Puente, B ^a   Disse, E ^b,c,d,e,f,g   Rabasa Lhoret, R ^h,i,j   Laville, M ^b,c,d,e,f,g   Capeau, J ^a,k,l   Bastard, J P ^a,k,l  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSERM   (France)

^d CEMAGREF   (France)

^e UNIVERSITÉ DE LYON   (France)

^f UNIVERSITÉ LYON 1   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^j CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^k HÔPITAL TENON   (France)

^l Centre de Recherche en Nutrition Humaine d'Lle de france   (France)

more..

Author keywords

HOMA; Hyperinsulinaemic euglycaemic glucose clamp; Insulin resistance; Insulin sensitivity; OGTT; QUICKI; Review

Indexed keywords

GLUCOSE; INSULIN;

CLINICAL RESEARCH; ENDOCRINE FUNCTION TEST; FREQUENTLY SAMPLED INTRAVENOUS GLUCOSE TOLERANCE TEST; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE INTOLERANCE; HOMOEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERINSULINEMIC EUGLYCEMIC GLUCOSE CLAMP TEST; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SUPPRESSION TEST; INTRAVENOUS GLUCOSE TOLERANCE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; REVIEW;

GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE;

EID: 79959257701     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.01.002     Document Type: Review

References (80)

1. Saltiel A., Kahn R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
2. Groop L.C., Bonadonna R.C., DelPrato S., Ratheiser K., Zyck K., Ferrannini E., et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. J Clin Invest 1989, 84:205-213.
3. Fritsche L., Weigert C., Haring H.U., Lehmann R. How insulin receptor substrate regulate the metabolic capacity of the liver- implications for health and disease. Curr Med Chem 2008, 15:1316-1329.
4. Cho H., Mu J., Kim J.K., Thorvaldsen Jl, Chu Q., Crenshaw E.B., et al. Insulin resistance and diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 2001, 292:1728-1731.
5. Rome S., Clément K., Rabasa-Lhoret R., Loizon E., Poitou C., Barsh G.S., et al. Microarray profiling of human skeletal muscle revels that insulin regulates approximately 800 genes during a hyperinsulinaemic clamp. J Biol Chem 2003, 278:18063-18068.
6. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
7. Bloomgarden Z. Insulin resistance concepts. Diabetes Care 2007, 30:1320-1326.
8. Messier V., Karelis A.D., Prud'homme D., Primeau V., Brochu M., Rabasa-Lhoret R. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity 2010, 18:911-917.
9. Conus F., Rabasa-Lhoret R., Péronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007, 32:4-12.
10. Wallace T.M., Matthews D.R. The assessment of insulin resistance in man. Diabet Med 2002, 19:527-534.
11. Ferranini E., Mari A. How to measure insulin sensitivity. J Hypert 1998, 16:895-906.
12. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000, 85:4426-4433.
13. Rabasa-Lhoret R., Laville M. How to measure insulin sensitivity in clinical practice?. Diabetes Metab 2001, 27(2 Pt 2):201-208.
14. Scheen A.J. Comment apprécier chez l'homme l'action de l'insuline en recherche et en pratique. Ann Endocrinol (Paris) 1999, 60:179-187.
15. Scheen A.J. Évaluation de l'insulinosécrétion et de l'insulinosensibilité chez l'homme. Therapie 2007, 62:311-318.
16. Choukem S.P., Gautier J.F. How to measure hepatic insulin resistance?. Diabetes Metab 2008, 34:664-673.
17. Muniyappa R., Lee S., Chen H., Quon M.J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-E26.
18. Matsuda M. Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis 2010, 20:79-86.
19. Manley S.E., Stratton I.M., Clark P.M., Luzio S.D. Comparison of 11 human insulin assays: implications for clinical investigation and research. Clin Chem 2007, 53:922-932.
20. Staten M.A., Stern M.P., Miller W.G., Steffes M.W., Campbell S.E. Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care. Diabetes Care 2010, 33:205-206. and Insulin Standardization Workgroup.
21. Miller W.G., Thienpont L.M., Van Uytfanghe K., Clark P.M., Lindstedt P., Nilsson G., et al. Toward standardization of insulin immunoassays. Clin Chem 2009, 55:1011-1018.
22. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-E223.
23. Nauck M.A., Blietz R.W., Qualmann C. Comparison of hyperinsulinaemic clamp experiments using venous, " arterialized" venous, or capillary euglycaemia. Clin Physiol 1996, 16:589-602.
24. Gniuli D., Castagneto-Gissey G., Iaconelli A., Leccesi L., Mingrone G. Fat mass largely contributes to insulin mediate glucose uptake in morbidly obese subjects. Int J Obes (Lond) 2010, 34:1726-1732.
25. Rizza R.A., Mandarino L.J., Gerich J.E. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981, 240:E630-E639.
26. Karelis A.D., Henry J.F., Malita F., St-Pierre D.H., Vigneault I., Poehlman E.T., et al. Comparison of insulin sensitivity values using the hyperinsulinemic euglycemic clamp: 2 vs 3hours. Diabetes Metab 2004, 30:413-414.
27. Shen S.W., Reaven G.M., Farquhar J.W. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and subjects with latent diabetes. J Clin Invest 1970, 49:2151-2160.
28. Bergman R.N., Prager R., Volund A., Olefsky J.M. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycaemic glucose clamp. J Clin Invest 1987, 79:790-800.
29. Bergman R.N., Phillips L.S., Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and Bcell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981, 68:1456-1467.
30. Cobelli C., Ruggeri A. A reduced sampling schedule for estimating the parameters of the glucose minimal model from a labeled IVGTT. IEEE Trans Biomed Eng 1991, 38:1023-1029.
31. Welch S., Gebhart S.S., Bergman R.N., Phillips L.S. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990, 71:1508-1518.
32. Matsuda M., DeFronzo R. Insulin sensitivity indexes obtained from oral glucose tolerance testing, comparison with the euglycaemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
33. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Jarvinen H., Van Haeften T., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000, 23:295-301.
34. Cederholm J., Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990, 10:167-175.
35. Belfiore F., Iannello S., Volpicelli G. Insulin sensitivity indexes calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Gen Metab 1998, 63:134-141.
36. Avignon A., Boegner C., Mariano-Goulart D., Colette C., Monnier L. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes 1999, 23:512-517.
37. Gutt M., Davis C.L., Spitzer S.B., Llabre M.M., Kumar M., Czarnecki E.M., et al. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 2000, 47:177-184.
38. Mari A., Pacini G., Murphy E., Ludvik B., Nolan J.J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001, 24:539-548.
39. Vangipurapu J., Stancaková A., Kuulasmaa T., Paananen J., Kuusisto J., et al. A novel surrogate index for hepatic insulin resistance. Diabetologia 2011, 54:540-543.
40. Bastard J.P., Vandernotte J.M., Faraj M., Karelis A.D., Messier L., Malita F.M., et al. Relationship between the hyprinsulinaemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women. Diabetes Metab 2007, 33:261-268.
41. Soonthornpun S., Setasuban W., Thamprasit A., Chayanunnukul W., Rattarasarn C., Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 2003, 88:1019-1023.
42. Abdul-Ghani M.A., Matsuda M., Balas B., DeFronzo R.A. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 2007, 30:89-94.
43. Hücking K., Watanabe R.M., Stefanovski D., Bergman R.N. OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself. Obesity 2008, 16:1938-1945.
44. Cheng C., Campbell K.L., Kushner H., Falkner B.E. Correlation of oral glucose tolerance test-derived estimates of insulin sensitivity with insulin clamp measurements in an African-American cohort. Metabolism 2004, 53:1107-1112.
45. Pigeon E., Riou M.E., St-Onge J., Couillard E., Tremblay A., Marette A., et al. Validation of a simple index (SIisOGTT) of insulin sensitivity in a population of sedentary men. Diabetes Metab 2009, 35:398-403.
46. Antuna-Puente B., Disse E., Lavoie M.E., Rabasa-Lhoret R., Laville M., Bastard J.P. Evaluation of the SIisOGTT index in a healthy population with normal glucose tolerance. Diabetes Metab 2009, 35:236-237.
47. Lorenzo C., Haffner S.M., Stancakova A., Laakso M. Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic Finnish offspring of Type 2 diabetic individuals. J Clin Endocrinol Metab 2010, 95:5082-5090.
48. Malita F.M., Messier V., Lavoie J.M., Bastard J.P., Rabasa-Lhoret R., Karelis A.D. Comparison between several insulin sensitivity indexes and metabolic risk factors in overweight and obese postmenopausal women: a MONET study. Nutr Metab Cardiovasc Dis 2010, 20:173-179.
49. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57-63.
50. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
51. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
52. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modelling. Diabetes Care 2004, 27:1487-1495.
53. Stern S.E., Williams K., Ferrannini E., DeFronzo R.A., Bogardus C., Stern M.P. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005, 54:333-339.
54. Levy J., Matthews D., Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21:2191-2192.
55. Bastard J.P., Robert J.J., Jardel C., Bruckert E., Grimaldi A., Hainque B. Is quantitative insulin sensitivity check index, a fair insulin sensitivity index in humans?. Diabetes Metab 2001, 27:69-70.
56. Katsuki A., Sumida Y., Gabazza E.C., Murashima S., Urakawa H., Morioka K., et al. QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2002, 87:2906-2908.
57. Chen H., Sullivan G., Yu L., Katz A., Quon M.J. QUICKI is a useful index of insulin sensitivity in subjects with hypertension. Am J Physiol Endocrinol Metab 2003, 284:E804-E812.
58. Chen H., Sullivan G., Quon M.J. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005, 54:1914-1925.
59. Bastard J.P., Rabsa-Lhoret R., Maachi M., Vidal H., Laville M. What kind of simple fasting index should be used to measure insulin sensitivity in human?. Diabetes Metab 2003, 29:285-288.
60. Vaccaro O., Masulli M., Cuomo V., Albarosa Riveliese A.A., Uusitupa M., Vessby B., et al. Comparative evaluation of simple indexes of insulin resistance. Metabolism 2004, 53:1522-1526.
61. Antuna-Puente B., Faraj M., Karelis A.D., Garrel D., Prud'homme D., Rabasa-Lhoret R., et al. HOMA or QUICKI: is it useful to test the reproducibility of formulas?. Diabetes Metab 2008, 34:294-296.
62. Skrha J., Haas T., Sindelka G., Prázný M., Widimský J., Cibula D., et al. Comparison of the insulin action parameters from hyperinsulinaemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. J Clin Endocrinol Metab 2004, 89:135-141.
63. Yeni-Komshian H., Carantoni M., Abbasi F., Reaven G.M. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000, 23:171-175.
64. Kanauchi M., Tsujimoto N., Hashimoto T. Validation of simple indexes to assess insulin sensitivity based on the oral glucose tolerance test in Japanese population. Diabetes Res Clin Pract 2002, 55:229-235.
65. Kanauchi M., Yamano S., Kanauchi K., Saito Y. Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure. J Clin Endocrinol Metab 2003, 88:3444-3446.
66. Ferrara C., Goldberg A. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes care 2001, 24:245-249.
67. Malita F.M., Karelis A.D., St-Pierre D.H., Garrel D., Bastard J.P., Tardif A., et al. Surrogate indexes vs. euglycaemic-hyperinsulinemic clamp as an indicator of insulin resistance and cardiovascular risk factors in overweight and obese postmenopausal women. Diabetes Metab 2006, 32:251-255.
68. Ruige J.B., Mertens I.L., Bartholomeeusen E., Dirinck E., Ferrannini E., Van Gaal L.F. Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal. Obesity 2006, 14:1250-1256.
69. Perseghin G., Caumo A., Caloni M., Testolin G., Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in non obese individuals. J Clin Endocrinol Metab 2001, 86:4776-4781.
70. Rabasa-Lhoret R., Bastard J.P., Jan V., Ducluzeau P.H., Andreelli F., Guebre F., et al. Modified quantitative insulin sensitivity check index is better correlated to hyprinsulinaemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 2003, 88:4917-4923.
71. Brady L.M., Gower B.A., Lovegrove S.S., Williams C.M., Lovegrove J.A. Revised QUICKI provides a strong surrogate estimate of insulin sensitivity when compared with the minimal model. Int J Obes Relat Metab Disord 2004, 28:222-227.
72. Bastard J.P., Jan V., Maachi M., Rabasa-Lhoret R., Jardel C., Bruckert E., et al. Incorporation of non esterified Fatty Acids into QUICKI is not relevant in Obese Subjects during diet inducing weight loss. Diabetes Metab 2002, 28:333-334.
73. McAuley K.A., Williams S.M., Mann J.I., Walker R.J., Lewis-Barned N.J., Temple L.A., et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001, 24:460-464.
74. Guerrero-Romero F., Simental-Mendía L.E., González-Ortiz M., Martínez-Abundis E., Ramos-Zavala M.G., Hernández-González S.O., et al. The product of triglycérides and glucose, a simple measure of insulin sensitivity. Comparison with the clamp euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010, 95:3347-3351.
75. Disse E., Bastard J.P., Bonnet F., Maitrepierre C., Peyrat J., Louche-Pelissier C., et al. A lipid-parameter-based index for estimating insulin sensitivity and identifying insulin resistance in healthy populations. Diabetes Metab 2008, 34:457-463.
76. Antuna-Puente B., Disse E., Faraj M., Lavoie M.E., Laville M., Rabasa-Lhoret R., et al. Evaluation of insulin sensitivity with a new lipid-based index in non-diabetic postmenopausal overweight and obese women before and after a weight loss intervention. Eur J Endocrinol 2009, 161:51-56.
77. Bastard J.P., Antuna-Puente B., Rabasa-Lhoret R. Is it important to reduce inter- and intra-individual variations to explore insulin sensitivity?. Diabetes Metab 2010, 36:249. [Epub].
78. Rajala U., Laakso M., Päivänsalo M., Pelkonen O., Suramo I., Keinänen-Kiukaanniemi S. Low insulin sensitivity measured by both quantitative insulin sensitivity check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery. J Clin Endocrinol Metab 2002, 87:5092-5097.
79. Hanley A.J., Williams K., Gonzalez C., D'Agostino R.B., Wagenknecht L.E., Stern M.P., et al. Prediction of Type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 2003, 52:463-469.
80. Robins S.J., Rubins H.B., Faas F.H., Schaefer E.J., Elam M.B., Anderson J.W., et al. Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care 2003, 26:1513-1517.